National antimicrobial stewardship and fluoroquinolone-resistant Clostridium difficile in China

被引：5
|
作者：
Xiao, Meng [1 ]
Cheng, Jing-Wei [1 ,2 ]
Kudinha, Timothy [3 ]
Kong, Fanrong [4 ]
Xu, Ying-Chun [1 ,2 ]
机构：
[1] Beijing Union Med Coll Hosp, Dept Clin Lab, Shuaifuyuan St 1, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Fac Clin Lab Diagnost, Beijing, Peoples R China
[3] Charles Sturt Univ, Sch Biomed Sci, Orange, NSW, Australia
[4] Univ Sydney, Ctr Infect Dis & Microbiol Lab Serv, ICPMR Pathol West, Westmead Hosp, Westmead, NSW, Australia
来源：
INFECTION AND DRUG RESISTANCE | 2017年 / 10卷
关键词：
INFECTION;
D O I：
10.2147/IDR.S149293
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
In a recent report, Dingle et al showed that national intervention programs aimed at judicious antimicrobial usage, especially restrictions to fluoroquinolones, contributed to a significant decrease in Clostridium difficile infection (CDI) in England.1 This is considered an outstanding achievement in combating antimicrobial resistance worldwide. © 2017 Xiao et al.
引用
收藏
页码：329 / 331
页数：3
相关论文
共 50 条
  • [1] Fluoroquinolone restriction to control fluoroquinolone-resistant Clostridium difficile
    Donskey, Curtis J.
    [J]. LANCET INFECTIOUS DISEASES, 2017, 17 (04): : 353 - 354
  • [2] gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027
    Drudy, Denise
    Kyne, Lorraine
    O'Mahony, Rebecca
    Fanning, Seamus
    [J]. EMERGING INFECTIOUS DISEASES, 2007, 13 (03) : 504 - 505
  • [3] Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile
    Pawlowski, S. W.
    Archbald-Pannone, L.
    Carman, R. J.
    Alcantara-Warren, C.
    Lyerly, D.
    Genheimer, C. W.
    Gerding, D. N.
    Guerrant, R. L.
    [J]. JOURNAL OF HOSPITAL INFECTION, 2009, 73 (02) : 185 - 187
  • [4] The Antimicrobial Stewardship Approach to Combating Clostridium Difficile
    Wenzler, Eric
    Mulugeta, Surafel G.
    Danziger, Larry H.
    [J]. ANTIBIOTICS-BASEL, 2015, 4 (02): : 198 - 215
  • [5] Emergence and control of fluoroquinolone-resistant, toxin a-negative, toxin B-Positive Clostridium difficile
    Drudy, Denise
    Harnedy, Norma
    Fanning, Seamus
    Hannan, Margaret
    Kyne, Lorraine
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (08): : 932 - 940
  • [6] Antimicrobial activity of sitafloxacin against fluoroquinolone-resistant Neisseria gonorrhoeae
    Hamasuna, R.
    Sho, T.
    Matsumoto, M.
    Matsumoto, T.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S71 - S71
  • [7] The Intersection Between Colonization Resistance, Antimicrobial Stewardship, and Clostridium difficile
    Rossana Rosa
    Curtis J. Donskey
    L. Silvia Munoz-Price
    [J]. Current Infectious Disease Reports, 2018, 20
  • [8] Effect of an antimicrobial stewardship bundle for patients with Clostridium difficile infection
    Brumley, Paul E.
    Malani, Anurag N.
    Kabara, Jared J.
    Pisani, Jennifer
    Collins, Curtis D.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (03) : 836 - 840
  • [9] The Intersection Between Colonization Resistance, Antimicrobial Stewardship, and Clostridium difficile
    Rosa, Rossana
    Donskey, Curtis J.
    Munoz-Price, L. Silvia
    [J]. CURRENT INFECTIOUS DISEASE REPORTS, 2018, 20 (08)
  • [10] Fluoroquinolone-resistant Salmonella Paratyphi A
    Adachi, T
    Sagara, H
    Hirose, K
    Watanabe, H
    [J]. EMERGING INFECTIOUS DISEASES, 2005, 11 (01) : 172 - 174
12345